HighTower Advisors’s Viracta Therapeutics, Inc. Common Stock VIRX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2014 Q4	–	Sell	-116	Closed	-$174K	–	1670
2014 Q3	$174K	Buy	116 +45	+63%	+$67.5K	﹤0.01%	1370
2014 Q2	$98K	Buy	71 +23	+48%	+$31.7K	﹤0.01%	1459
2014 Q1	$66K	Buy	+48	New	+$66K	﹤0.01%	1385